Discover
BOLD
Boundless Bio, Inc.
2.48
2 x 1.78
2 x 3.16
bid
ask
-
0.02
0.80%
2 @ 07:31 AM
2.53 +0.05 (2.04%)
| Ytd | 106.67% | |
| 1y | 133.96% |
2.46
day range
2.52
0.96
52 week range
2.79
| Open | 2.47 | Prev Close | 2.50 | Low | 2.46 | High | 2.52 | Mkt Cap | 55.74M |
| Vol | 329.17K | Avg Vol | 1.35M | EPS | -2.49 | P/E | N/A | Forward P/E | -0.70 |
| Beta | N/A | Short Ratio | 2.01 | Inst. Own | 75.86% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | 1.62 | 200-d Avg | 1.31 | 1yr Est | 14.50 |
| Income Statement | |||
| Operating Expenses | 14.48M | ||
| Research and Development Expense | 9.73M | ||
| Selling, General and Administrative Expense | 4.74M | ||
| Operating Income | -14.47M | ||
| Net Income | -13.55M | ||
| Net Income Common Stock | -13.55M | ||
| Net Income Common Stock (USD) | -13.55M | ||
| Consolidated Income | -13.55M | ||
| Earnings per Basic Share | -0.60 | ||
| Earnings per Basic Share (USD) | -0.60 | ||
| Earnings per Diluted Share | -0.60 | ||
| Earning Before Interest & Taxes (EBIT) | -13.55M | ||
| Earning Before Interest & Taxes (USD) | -13.55M | ||
| Weighted Average Shares | 22.41M | ||
| Weighted Average Shares Diluted | 22.41M | ||
| Balance Sheet | |||
| Cash and Equivalents | 18.04M | ||
| Cash and Equivalents (USD) | 18.04M | ||
| Investments | 75.36M | ||
| Investments Current | 75.36M | ||
| Current Assets | 94.62M | ||
| Property, Plant & Equipment Net | 45.77M | ||
| Total Assets | 140.97M | ||
| Debt Current | 3.28M | ||
| Total Debt | 48.29M | ||
| Current Liabilities | 9.58M | ||
| Debt Non-Current | 45.00M | ||
| Total Liabilities | 54.59M | ||
| Accumulated Retained Earnings (Deficit) | -273.22M | ||
| Accumulated Other Comprehensive Income | -23.00K | ||
| Shareholders Equity | 86.38M | ||
| Shareholders Equity (USD) | 86.38M | ||
| Assets Non-Current | 46.35M | ||
| Total Debt (USD) | 48.29M | ||
| Liabilities Non-Current | 45.00M | ||
| Trade and Non-Trade Payables | 5.71M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 1.11M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -385.00K | ||
| Capital Expenditure | -8.00K | ||
| Net Cash Flow from Investing | 14.59M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 14.60M | ||
| Net Cash Flow from Operations | -14.97M | ||
| Share Based Compensation | 1.37M | ||